Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage biopharmaceutical company ...

With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. [Adobe Stock ...

CRScube is a leading APAC provider of clinical research technology, headquartered in South Korea. With a focus on innovation ...

[x] Throughout the supply chain the logistics involved in managing comparator drugs has grown vastly more complex in recent years. Clinical studies are increasingly conducted in remote locations ...

Clinical trial organizers and biomanufacturers, however, face headwinds. According to Global Data analysis, supply chain disruptions emerged as a top concern for pharmaceutical executives in the first ...

Canadian psychedelic stock PharmAla Biotech (CSE:MDMA) is up after signing a contract to supply MDMA for a clinical trial at Yale University ・The company is actively expanding its roster of research ...

This agreement builds on the earlier MSA and Clinical Supply Agreements with NorthStar for the production of 67Cu-SAR-bisPSMA1, allowing Clarity to continue building supply chain capacity ahead of a ...

Also known as a polymyxin B haemoperfusion (PMX), Toraymyxin is a haemoperfusion device that removes endotoxin, a toxic ...

our expectations and plans regarding our clinical supply agreement with BeiGene; our plans to advance clinical evaluation of the combination of BeiGene’s anti-PD-1 antibody, tislelizumab, with Decoy20 ...